Greater Monoamine Oxidase a Binding in Alcohol Dependence
Overview
Authors
Affiliations
Background: Alcohol dependence (AD) is a multiorgan disease in which excessive oxidative stress and apoptosis are implicated. Monoamine oxidase A (MAO-A) is an important enzyme on the outer mitochondrial membrane that participates in the cellular response to oxidative stress and mitochondrial toxicity. It is unknown whether MAO-A levels are abnormal in AD. We hypothesized that MAO-A VT, an index of MAO-A level, is elevated in the prefrontal cortex (PFC) during AD, because markers of greater oxidative stress and apoptosis are reported in the brain in AD and a microarray analysis reported greater MAO-A messenger RNA in the PFC of rodents exposed to alcohol vapor.
Methods: Sixteen participants with alcohol dependence and 16 healthy control subjects underwent [(11)C]-harmine positron emission tomography. All were nonsmoking, medication- and drug-free, and had no other past or present psychiatric or medical illnesses.
Results: MAO-A VT was significantly greater in the PFC (37%, independent samples t test, t₃₀ = 3.93, p < .001), and all brain regions analyzed (mean 32%, multivariate analysis of variance, F₇,₂₄ = 3.67, p = .008). Greater duration of heavy drinking correlated positively with greater MAO-A VT in the PFC (r = .67, p = .005) and all brain regions analyzed (r = .73 to .57, p = .001-.02).
Conclusions: This finding represents a new pathological marker present in AD that is therapeutically targetable through direct inhibition or by novel treatments toward oxidative/pro-apoptotic processes implicated by MAO-A overexpression.
Type A monoamine oxidase; its unique role in mood, behavior and neurodegeneration.
Naoi M, Maruyama W, Shamoto-Nagai M, Riederer P J Neural Transm (Vienna). 2024; 132(3):387-406.
PMID: 39621110 DOI: 10.1007/s00702-024-02866-z.
Castle M, Flanigan M Neurobiol Stress. 2024; 30:100618.
PMID: 38433994 PMC: 10907856. DOI: 10.1016/j.ynstr.2024.100618.
Handschuh P, Murgas M, Vraka C, Nics L, Hartmann A, Winkler-Pjrek E Int J Neuropsychopharmacol. 2022; 26(2):116-124.
PMID: 36573644 PMC: 9926052. DOI: 10.1093/ijnp/pyac085.
Tsermpini E, Plemenitas Iljes A, Dolzan V Antioxidants (Basel). 2022; 11(7).
PMID: 35883865 PMC: 9311529. DOI: 10.3390/antiox11071374.
Attwells S, Setiawan E, Rusjan P, Xu C, Kish S, Vasdev N Transl Psychiatry. 2021; 11(1):334.
PMID: 34052828 PMC: 8164633. DOI: 10.1038/s41398-021-01450-3.